Pivotal data for Novartis' investigational compound LDE225 show marked tumor responses in advanced basal cell carcinoma
Source URL: https://qa1.novartis.us/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma-0
List of links present in page
- https://qa1.novartis.us/news/media-releases/pivotal-data-novartis-investigational-compound-lde225-show-marked-tumor-responses-advanced-basal-cell-carcinoma-0